OMNIlife science, Inc. Announces the Successful Completion of 1000 Knee Replacements Utilizing OMNI’s APEX Robotic Technology (“A.R.T.™”)

Share Article

APEX Robotic Technology™ is a surgical navigation product of PRAXIM®, a sister company to OMNIlife science®. A.R.T.™ empowers the surgeon with intelligent instrumentation that allows intra-operative customization to accurately place the knee implant as intended.

News Image
Today the marriage of computer navigation and robotic technology will further advance what is already a highly successful total knee replacement procedure.

OMNIlife science, Inc., a company dedicated to the design, manufacture, and distribution of high quality medical devices developed specifically for the orthopedics segment of healthcare, today announced the successful completion of 1000 knee replacements utilizing OMNI’s APEX Robotic Technology (“A.R.T.™”).

APEX Robotic Technology™ is a surgical navigation product of PRAXIM®, a sister company to OMNIlife science®. A.R.T.™ empowers the surgeon with intelligent instrumentation that allows intra-operative customization to accurately place the knee implant as intended. This is made possible in part by PRAXIM®’s patented BoneMorphing® technology that creates a precise virtual 3D model of the patient’s anatomy, which in turn provides accurate positioning of an automated bone cutting guide. A.R.T.™ addresses key issues associated with conventional surgical procedures, including improving bone cutting precision, to produce ideal leg alignment.

OMNI’s President and CEO, George Cipolletti, noted, “Universal manual knee instruments were a technical breakthrough in the 1990s and computer navigation showed great promise when introduced approximately 15 years ago. Today the marriage of computer navigation and robotic technology will further advance what is already a highly successful total knee replacement procedure. Clinical studies show that the A.R.T.™ platform allows the surgeon to achieve increased implant placement accuracy within operative times that are comparable to traditional manual instrumentation. More important is the fact that these results were achieved over a very short learning curve period during which no compromise in implant placement accuracy was observed.”

About OMNIlife science, Inc.
OMNIlife science, Inc. was founded in 1999 as an organization committed to the design, manufacture and distribution of high quality orthopaedic devices. Our corporate headquarters are located in East Taunton, Massachusetts. Our products are prescribed by orthopaedic surgeons for their patients who require total joint replacement. OMNI is ISO 13485 certified and its products are FDA cleared and CE approved. OMNI is emerging as a leader in modular hip stem technology and total knee replacement systems. We continue to challenge the design and functionality of our products based on continued advances in reconstructive surgical techniques, anatomic and biomechanical data, as well as input from surgeons. Our corporate strategic objectives include continued growth through line extensions to our hip and knee product offerings as well as the introduction of new products that will complement our current product portfolio and allow us to provide new clinical options for our customers. Additional information can be found at http://www.omnils.com.

About PRAXIM, Inc.
Praxim™, Inc. develops and commercializes advanced navigation systems, software and instruments in order to make total knee arthroplasty less-invasive, more reliable, faster and more cost-effective for both patients and surgeons. The Company’s technology platform addresses key issues associated with conventional surgical procedures – including the malalignment of bones that ultimately lead to joint failure. These can be avoided by providing highly innovative imaging protocols and advanced smart instrumentation in the operating room. Additional information can be found at http://www.praxim.fr.

About Orthopaedic Synergy, Inc.
Orthopaedic Synergy, Inc. functions as a holding company for OMNIlife science, Inc., Enztec Limited and PRAXIM, SA. Together these companies represent a global reconstructive orthopaedic concern that is committed to the design, manufacture and distribution of high quality orthopaedic devices. Company objectives include continued growth through strategic acquisition of organizations with complementary technology. The goal is to acquire firms that enhance the development of line extensions to our company’s current product offerings as well as innovative new products that provide improved clinical options for our customers. Additional information can be found at http://www.orthopedicsynergy.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lisa Cabral
Visit website